Successful treatment of gonococcal osteomyelitis with one week of intravenous antibiotic therapy

Abstract

Gonorrhea is one of the most common sexually transmitted infections (STIs). In a minority of cases, a disseminated infection can occur including gonococcal osteoarticular disease. With the steep and sustained increase in STIs in the US, we could see invasive gonococcal disease more often. Most cases of gonococcal osteomyelitis receive prolonged courses of antibiotic therapy. We report here the successful treatment of gonococcal osteomyelitis with one week of antibiotic therapy. Given the emergence of bacterial resistance worldwide and associated side effects, it is crucial to limit antibiotic exposures to the smallest effective dose possible. © The Author(s) 2019.

Description

Keywords

Duration, Gonorrhea, Osteomyelitis, Treatment, Administration, intravenous, Adult, Anti-bacterial agents, Humans, Male, Neisseria gonorrhoeae, Time factors, Treatment outcome, Azithromycin, C reactive protein, Ceftriaxone, Vancomycin, Antiinfective agent, Antibiotic resistance, Antibiotic therapy, Antimicrobial stewardship, Article, Bone biopsy, Case report, Cellulitis, Clinical article, Debridement, Follow up, Foot pain, Granulocyte, Home health agency, Human, Leukocyte count, Neutrophil, Nuclear magnetic resonance imaging, Priority journal, Treatment duration, Urethritis, Drug effect, Intravenous drug administration, Isolation and purification, Microbiology, Time factor

Citation

Endorsement

Review

Supplemented By

Referenced By